Skip to main content
SpringerLink
Log in

Spontaneous bacterial peritonitis: from pathophysiology to prevention

  • Symposium: Spontaneous Bacterial Peritonitis: Pathophysiology, Prevention, Therapy and Emergency of Multiresistant Bacterial Strains
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

Abstract

Patients with cirrhosis present an increased susceptibility to bacterial infections, which are the cause of hospital admission in about 10% of patients and are present in about 40% of those admitted for ongoing complications. Lastly, about a third of patients develop nosocomial infections. Spontaneous bacterial peritonitis (SBP) is the most frequent infection in advanced cirrhosis; it is mostly caused by Gram-negative bacteria of intestinal origin, but Gram-positive cocci can be involved in nosocomial-acquired SBP. Its occurrence is associated with complications, such as renal and circulatory failure, cardiac dysfunction, coagulopathy, encephalopathy, and relative adrenal insufficiency, ultimately leading to multi-organ failure and death within a few days or weeks in about 30% of cases. The main mechanism underlying the development of SBP, as well as other bacterial infections in cirrhosis, is represented by bacterial translocation from the intestinal lumen to mesenteric lymph nodes or other extraintestinal organs and sites. This process is facilitated by several factors, including changes in intestinal flora, portal hypertension, and, mainly, impairment in local/systemic immune defense mechanisms. Bacterial infections in advanced cirrhosis evoke an enhanced systemic inflammatory response, which explains the ominous fate of PBS. Indeed, an exaggerated production of cytokines ensues, which ultimately activates vasodilating systems and generates reactive oxygen species. Primary antibiotic prophylaxis of PBS is warranted in those conditions implying an increased incidence of bacterial infections, such as gastro-intestinal bleeding and low protein content in ascites associated with severe liver and/or renal dysfunction. Fluoroquinolones are commonly employed, but the frequent occurrence of resistant bacterial strains make third generation cephalosporins preferable in specific settings. The high PBS recurrence indicates secondary antibiotic prophylaxis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wong F, Bernardi M, Balk R et al (2005) Sepsis in cirrhosis: report on the 7th meeting of the international ascites club. Gut 54:718–725

    Article  CAS  PubMed  Google Scholar 

  2. Trevisani F, Castelli E, Foschi FG et al (2002) Impaired tuftsin activity in cirrhosis. Relationship with splenic function and clinical outcome. Gut 50:707–712

    Article  CAS  PubMed  Google Scholar 

  3. Borzio M, Salerno F, Piantoni L et al (2001) Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 33:41–48

    Article  CAS  PubMed  Google Scholar 

  4. Campillo B, Dupeyron C, Richardet JP (2001) Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis. Epidemiol Infect 127:443–450

    Article  CAS  PubMed  Google Scholar 

  5. Tandon P, Garcia-Tsao G (2008) Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis 28:26–42

    Article  CAS  PubMed  Google Scholar 

  6. Gustot T, Durand F, Lebrec D et al (2009) Severe sepsis in cirrhosis. Hepatology 50:2022–2033

    Article  CAS  PubMed  Google Scholar 

  7. Sen S, Williams R, Jalan R (2002) The pathophysiological basis of acute-on-chronic liver failure. Liver 22(Suppl 2):5–13

    PubMed  Google Scholar 

  8. Garcia-Tsao G, Wiest R (2004) Gut microflora in the pathogenesis of the complications of cirrhosis. Best Pract Res Clin Gastroenterol 18:353–372

    Article  PubMed  Google Scholar 

  9. Bauer TM, Schwacha H, Steinbruckner B et al (2002) Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am J Gastroenterol 97:2364–2370

    Article  PubMed  Google Scholar 

  10. Pardo A, Bartoli R, Lorenzo-Zuniga V et al (2001) Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology 31:858–863

    Article  Google Scholar 

  11. Slocum MM, Sittig KM, Specian RD et al (1992) Absence of intestinal bile promotes bacterial translocation. Am Surg 58:305–310

    CAS  PubMed  Google Scholar 

  12. Eaves-Pyles T, Alexander JW (2001) Comparison of translocation of different types of microorganisms from the intestinal tract of burned mice. Shock 16:148–152

    Article  CAS  PubMed  Google Scholar 

  13. Misra V, Misra S, Dwivedi M et al (1997) Histomorphometric study of portal hypertensive enteropathy. Am J Clin Pathol 108:652–657

    CAS  PubMed  Google Scholar 

  14. Pascual S, Such J, Esteban A et al (2003) Intestinal permeability is increased in patients with advanced cirrhosis. Hepatogastroenterology 50:1482–1486

    PubMed  Google Scholar 

  15. Bolognesi M, Merkel C, Bianco S et al (1994) Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis. Hepatology 19:628–634

    Article  CAS  PubMed  Google Scholar 

  16. Fierer J, Finley F (1979) Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver. J Clin Invest 63:912–921

    Article  CAS  PubMed  Google Scholar 

  17. Nouri-Aria KT, Alexander GJ, Portmann BC et al (1986) T and B cell function in alcoholic liver disease. J Hepatol 2:195–207

    Article  CAS  PubMed  Google Scholar 

  18. Rajkovic IA, Williams R (1986) Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology 6:252–262

    Article  CAS  PubMed  Google Scholar 

  19. Altin M, Rajkovic IA, Hughes RD et al (1983) Neutrophil adherence in chronic liver disease and fulminant hepatic failure. Gut 24:746–750

    Article  CAS  PubMed  Google Scholar 

  20. Foschi FG, Trevisani F, Loggi E et al (2005) Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophil granulocytes in patients with liver cirrhosis. Int Arch Allergy Immunol 137:258–262

    Article  PubMed  Google Scholar 

  21. Such J, Guarner C, Enriquez J et al (1988) Low C3 in cirrhotic ascites predisposes to spontaneous bacterial peritonitis. J Hepatol 6:80–84

    Article  CAS  PubMed  Google Scholar 

  22. Ripoll C, Groszmann R, Garcia-Tsao G et al (2007) Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 133:481–488

    Article  CAS  PubMed  Google Scholar 

  23. Merli M, Riggio O, Dally L (1996) Does malnutrition affect survival in cirrhosis? Hepatology 23:1041–1046

    Article  CAS  PubMed  Google Scholar 

  24. Sam J, Nguyen GC (2009) Protein-calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension. Liver Int 29:1396–1402

    Article  PubMed  Google Scholar 

  25. Bone RC, Balk RA, Cerra FB et al (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644–1655

    Article  CAS  PubMed  Google Scholar 

  26. Groszmann RJ (1994) Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 20:1359–1363

    Article  CAS  PubMed  Google Scholar 

  27. Córdoba J, Mínguez B (2008) Hepatic encephalopathy. Semin Liver Dis 28:70–80

    Article  PubMed  Google Scholar 

  28. Garcia-Tsao G (1992) Spontaneous bacterial peritonitis. Gastroenterol Clin North Am 21:257–275

    CAS  PubMed  Google Scholar 

  29. Such J, Frances R, Munoz C et al (2002) Detection an identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites. Hepatology 36:135–141

    Article  CAS  PubMed  Google Scholar 

  30. Frances R, Munoz C, Zapater P et al (2004) Bacterial DNA activates cell mediated immune responses and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites. Gut 53:860–864

    Article  CAS  PubMed  Google Scholar 

  31. Akira S, Takeda K, Kaisho T (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2:675–680

    Article  CAS  PubMed  Google Scholar 

  32. Manigold T, Bocker U, Hanck C et al (2003) Differential expression of toll-like receptors 2 and 4 in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 15:275–282

    Article  CAS  PubMed  Google Scholar 

  33. Riordan SM, Skinner N, Nagree A et al (2003) Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology 37:1154–1164

    Article  CAS  PubMed  Google Scholar 

  34. Marsik C, Mayr F, Cardona F et al (2003) Endotoxaemia modulates Toll-like receptors on leucocytes in humans. Br J Haematol 121:653–656

    Article  CAS  PubMed  Google Scholar 

  35. Gustot T, Durand F, Lebrec D et al (2009) Severe sepsis in cirrhosis. Hepatology 50:2022–2033

    Article  CAS  PubMed  Google Scholar 

  36. Galbois A, Thabut D, Tazi KA et al (2009) Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis. Hepatology 49:175–184

    Article  CAS  PubMed  Google Scholar 

  37. Szabo G, Romics JL, Frendl G (2002) Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis 6:1045–1066

    Article  PubMed  Google Scholar 

  38. Ottesen LH, Harry D, Frost M et al (2001) Increased formation of S-nitrothiols and nitrotyrosine in cirrhotic rats during endotoxaemia. Free Radic Biol Med 31:790–798

    Article  CAS  PubMed  Google Scholar 

  39. Tazi KA, Quioc JJ, Saada V et al (2006) Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M. J Hepatol 45:280–289

    Article  CAS  PubMed  Google Scholar 

  40. Le Moine O, Marchant A, De Groote D et al (1995) Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis. Hepatology 22:1436–1439

    Article  CAS  PubMed  Google Scholar 

  41. Tschaikowsky K, Hedwig-Geissing M, Schiele A et al (2002) Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med 30:1015–1023

    Article  CAS  PubMed  Google Scholar 

  42. Lin CY, Tsai IF, Ho YP et al (2007) Endotoxemia contributes to the immune paralysis in patients with cirrhosis. J Hepatol 46:816–826

    Article  CAS  PubMed  Google Scholar 

  43. Wasmuth HE, Kunz D, Yagmur E et al (2005) Patients with acute on chronic liver failure display “sepsis-like” immune paralysis. J Hepatol 42:195–201

    Article  CAS  PubMed  Google Scholar 

  44. Fernández J, Navasa M, Gómez J et al (2002) Bacterial Infection in cirrhosis: epidemiological changes with invasive procedures and Norfloxacin prophylaxis. Hepatology 35:140–148

    Article  PubMed  Google Scholar 

  45. Caly WR, Strauss E (1993) A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 18:353–358

    Article  CAS  PubMed  Google Scholar 

  46. Toledo C, Salmeron JM, Rimola A et al (1993) Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology 17:251–257

    Article  CAS  PubMed  Google Scholar 

  47. Garcia-Tsao G (2004) Spontaneous bacterial peritonitis: a historical perspective. J Hepatol 41:522–527

    PubMed  Google Scholar 

  48. Cheong HS, Kang CI, Lee JA et al (2009) Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis. Clin Infect Dis 48:1230–1236

    Article  PubMed  Google Scholar 

  49. Runyon BA, Hoefs JC (1984) Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal tract perforation into ascitic fluid. Hepatology 4:447–450

    Article  CAS  PubMed  Google Scholar 

  50. Rimola A, Garcia-Tsao G, Navasa M et al (2000) Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 32:142–153

    Article  CAS  PubMed  Google Scholar 

  51. Xiol X, Castellvi JM, Guardiola J et al (1996) Spontaneous bacterial empyema in cirrhotic patients: a prospective study. Hepatology 23:719–723

    Article  CAS  PubMed  Google Scholar 

  52. Schrier RW, Arroyo V, Bernardi M et al (1988) Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8:1151–1157

    Article  CAS  PubMed  Google Scholar 

  53. Wiest R, Shah V, Sessa WC et al (1999) NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. Am J Physiol 276:G1043–G1051

    CAS  PubMed  Google Scholar 

  54. Bolognesi M, Sacerdoti D, Piva A et al (2007) Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats. J Pharmacol Exp Ther 321:187–194

    Article  CAS  PubMed  Google Scholar 

  55. Oberti F, Sogni P, Cailmail S et al (1993) Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension. Hepatology 18:621–627

    Article  CAS  PubMed  Google Scholar 

  56. Domenicali M, Ros J, Fernández-Varo G et al (2005) Increased anandamide-induced relaxation in mesenteric arteries of cirrhotic rats. role of cannabinoid and vanilloid receptors. Gut 54:522–532

    Article  CAS  PubMed  Google Scholar 

  57. Domenicali M, Caraceni P, Giannone F et al (2009) Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. Gastroenterology 137:341–349

    Article  CAS  PubMed  Google Scholar 

  58. Alqahtani SA, Fouad TR, Lee SS (2008) Cirrhotic cardiomyoparthy. Semin Liver Dis 28:59–69

    Article  CAS  PubMed  Google Scholar 

  59. Zambruni A, Trevisani F, Caraceni P et al (2006) Cardiac electrophysiological abnormalities in patients with cirrhosis. J Hepatol 44:994–1002

    Article  CAS  PubMed  Google Scholar 

  60. Moreau R, Hadengue A, Soupison T et al (1992) Septic shock in patients with cirrhosis: hemodynamic and metabolic characteristics and intensive care unit outcome. Crit Care Med 20:746–750

    Article  CAS  PubMed  Google Scholar 

  61. Bomzon A (1990) Vascular reactivity in liver disease. In: Bomzon A, Blendis LM (eds) Cardiovascular complications of liver disease. CRC Press Inc., Boca Raton, pp 207–223

    Google Scholar 

  62. Follo A, Llovet JM, Navasa M et al (1994) Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 20:1495–1501

    Article  CAS  PubMed  Google Scholar 

  63. Salerno F, Gerbes A, Gines P et al (2007) Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56:1310–1318

    CAS  PubMed  Google Scholar 

  64. Ruiz del Arbor L, Urman J, Fernandez J et al (2003) Systemic, renal and hepatic haemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 38:1210–1218

    Article  Google Scholar 

  65. Fasolato S, Angeli P, Dallagnese L et al (2007) Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology 45:223–229

    Article  PubMed  Google Scholar 

  66. Navasa M, Follo A, Filella X et al (1998) Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal failure and mortality. Hepatology 27:1227–1232

    Article  CAS  PubMed  Google Scholar 

  67. Ghassemi S, Garcia-Tsao G (2007) Prevention and treatment of infections in patients with cirrhosis. Best Pract Res Clin Gastroenterol 21:77–93

    Article  PubMed  Google Scholar 

  68. Shawcross DL, Davies NA, Williams R et al (2004) Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 40:247–254

    Article  CAS  PubMed  Google Scholar 

  69. Blei AT (2004) Infection, inflammation and hepatic encephalopathy, synergism redefined. J Hepatol 40:327–330

    Article  PubMed  Google Scholar 

  70. Plessier A, Denninger MH, Consigny Y et al (2003) Coagulation disorders in patients with cirrhosis and severe sepsis. Liver Int 23:440–448

    Article  PubMed  Google Scholar 

  71. Zambruni A, Thalheimer U, Coppell J et al (2004) Endogenous heparin-like activity detected by anti-Xa assays in cirrhotic and non-cirrhotic patients. Scand J Gastroenterol 39:830–836

    Article  CAS  PubMed  Google Scholar 

  72. Goulis J, Patch D, Burroughs AK (1999) Bacterial infection in the pathogenesis of variceal bleeding. Lancet 353:139–142

    Article  CAS  PubMed  Google Scholar 

  73. TenHoor T, Mannino DM, Moss M (2001) Risk factors for ARDS in the United States: analysis of the 1993 National Mortality Followback Study. Chest 119:1179–1184

    Article  CAS  PubMed  Google Scholar 

  74. Matuschak GM (1996) Lung–liver interactions in sepsis and multiple organ failure syndrome. Clin Chest Med 17:83–98

    Article  CAS  PubMed  Google Scholar 

  75. Tsai MH, Peng YS, Chen YC et al (2006) Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology 43:673–681

    Article  PubMed  Google Scholar 

  76. Tazi KA, Bieche I, Paradis V et al (2007) In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic rats. J Hepatol 46:1075–1088

    Article  CAS  PubMed  Google Scholar 

  77. Vivas S, Rodríguez M, Palacio MA et al (2001) Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding. Dig Dis Sci 46:2752–2757

    Article  CAS  PubMed  Google Scholar 

  78. Bernard B, Grange JD, Khac EN et al (1999) Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 29:1655–1661

    Article  CAS  PubMed  Google Scholar 

  79. Fernández J, Ruiz del Arbol L, Gómez C et al (2006) Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology 131:1049–1056

    Article  PubMed  Google Scholar 

  80. Fernández J, Navasa M, Planas R et al (2007) Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 133:818–824

    Article  PubMed  Google Scholar 

  81. Terg R, Fassio E, Guevara M et al (2008) Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study. J Hepatol 48:774–779

    Article  CAS  PubMed  Google Scholar 

  82. Ginès P, Rimola A, Planas R et al (1990) Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 12:716–724

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Dipartimento di Medicina Clinica, Alma Mater Studiorum, Semeiotica Medica, Policlinico S. Orsola-Malpighi, University of Bologna, Via Albertoni, 15, 40138, Bologna, Italy

    Mauro Bernardi

Authors
  1. Mauro Bernardi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mauro Bernardi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bernardi, M. Spontaneous bacterial peritonitis: from pathophysiology to prevention. Intern Emerg Med 5 (Suppl 1), 37–44 (2010). https://doi.org/10.1007/s11739-010-0446-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-010-0446-x

Keywords

Search

Navigation